|
Volumn 44, Issue 8, 2009, Pages 489-494
|
Erratum: Regionally limited or rare infections: Prevention after hematopoietic cell transplantation (Bone Marrow Transplantation (2009) 44 (489-494) DOI: 10.1038/bmt.2009.260);Regionally limited or rare infections: Prevention after hematopoietic cell transplantation
a a b c d e f g |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALBENDAZOLE;
ALEMTUZUMAB;
ATOVAQUONE;
BCG VACCINE;
BENZNIDAZOLE;
COTRIMOXAZOLE;
DAPSONE;
FLUCONAZOLE;
FLUDARABINE;
IMMUNOSUPPRESSIVE AGENT;
ISONIAZID;
ITRACONAZOLE;
NIFURTIMOX;
PENTAMIDINE;
PREDNISOLONE;
PYRAZINAMIDE;
PYRIDOXINE;
RIFAMPICIN;
ANTIBIOTIC PROPHYLAXIS;
ARTICLE;
AUTOLOGOUS STEM CELL TRANSPLANTATION;
BACTERIAL INFECTION;
BCG VACCINATION;
BONE MARROW SUPPRESSION;
BONE MARROW TRANSPLANTATION;
BRONCHOSPASM;
CHAGAS DISEASE;
CHRONIC GRAFT VERSUS HOST DISEASE;
DRUG ABSORPTION;
DRUG CONTRAINDICATION;
DRUG DOSE REDUCTION;
DRUG HYPERSENSITIVITY;
DRUG MEGADOSE;
DRUG POTENTIATION;
DRUG TOLERABILITY;
ENDEMIC DISEASE;
FOOD DRUG INTERACTION;
GRAFT RECIPIENT;
HEMOLYSIS;
HEPATITIS;
HUMAN;
HYPERKALEMIA;
IMMUNOCOMPROMISED PATIENT;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION;
INFECTION RISK;
INSECT BITE;
LIVER TOXICITY;
LYMPHATIC LEUKEMIA;
LYMPHOCYTE DEPLETION;
MALARIA;
METHEMOGLOBINEMIA;
MULTIDRUG RESISTANCE;
NEPHRITIS;
NOCARDIOSIS;
OCCUPATIONAL EXPOSURE;
OCCUPATIONAL SAFETY;
PANCREATITIS;
PATIENT ASSESSMENT;
PNEUMOCYSTIS PNEUMONIA;
PRIORITY JOURNAL;
RECURRENT INFECTION;
RISK FACTOR;
STRONGYLOIDIASIS;
TOXOPLASMA GONDII;
TOXOPLASMOSIS;
TREATMENT INDICATION;
TRYPANOSOMIASIS;
TUBERCULOSIS;
|
EID: 70350746513
PISSN: 02683369
EISSN: 14765365
Source Type: Journal
DOI: 10.1038/bmt.2010.51 Document Type: Erratum |
Times cited : (26)
|
References (0)
|